2'-OMe-phosphorodithioate-modified siRNAs show increased loading into the RISC complex and enhanced anti-tumour activity.
about
Preclinical and clinical development of siRNA-based therapeuticsRNAi therapies: drugging the undruggable.Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progression.Identification and phylogenetic analyses of VASt, an uncharacterized protein domain associated with lipid-binding domains in Eukaryotes.PTEN Expression as a Predictor of Response to Focal Adhesion Kinase Inhibition in Uterine Cancer.Role of CTGF in Sensitivity to Hyperthermia in Ovarian and Uterine Cancers.Erythropoietin Stimulates Tumor Growth via EphB4.A miR-192-EGR1-HOXB9 regulatory network controls the angiogenic switch in cancer.Hypoxia-upregulated microRNA-630 targets Dicer, leading to increased tumor progression.Evoking picomolar binding in RNA by a single phosphorodithioate linkage.Assessment of In Vivo siRNA Delivery in Cancer Mouse ModelsOligonucleotide aptamers: new tools for targeted cancer therapy.Determining Functional Aptamer-Protein Interaction by Biolayer Interferometry.Aptamers and their applications in nanomedicine.A Highlight of Recent Advances in Aptamer Technology and Its Application.Therapeutic potential of chemically modified siRNA: Recent trends.Solid-Phase Synthesis of Oligodeoxynucleotide Analogs Containing Phosphorodithioate Linkages.A ceRNA approach may unveil unexpected contributors to deletion syndromes, the model of 5q- syndrome.Amide linkages mimic phosphates in RNA interactions with proteins and are well tolerated in the guide strand of short interfering RNAs.Solid-Phase Synthesis of RNA Analogs Containing Phosphorodithioate Linkages.Selection of PD1/PD-L1 X-Aptamers.Origins of the enhanced affinity of RNA-protein interactions triggered by RNA phosphorodithioate backbone modification.GRAM domain-containing protein 1B (GRAMD1B), a novel component of the JAK/STAT signaling pathway, functions in gastric carcinogenesis.Development of Phosphorothioate DNA and DNA Thioaptamers.ZRANB1 Is an EZH2 Deubiquitinase and a Potential Therapeutic Target in Breast Cancer.GRAMD1B regulates cell migration in breast cancer cells through JAK/STAT and Akt signaling.
P2860
Q28085290-550E6E99-FF27-4879-BDE1-14B8F0EFA2C6Q34131220-B0ABB5AF-EEB4-4836-8E30-9E84A6ED51B8Q34433163-4D382F84-2DA7-4343-B8B9-B0528EE9B6B7Q35194975-0B8BD547-6121-4E85-8A23-1B36F338C8FAQ35691011-63A313F3-D0DB-43AD-AF11-F5F274B02ABEQ36180542-05EF074B-EE6F-47EA-84BD-9E42298B03ADQ36275814-922AF28E-B7BE-42FD-9431-FDF97CA93F19Q36768803-BAD5F208-EE35-4BBE-B7AD-C1EECC010241Q37062821-0D3BAE50-15B6-4593-B8DD-0AA85DB7F419Q37294897-E00ED366-741A-4327-B2EB-531C90AF5B4CQ37481788-B72C3922-0514-4B1E-A377-7E8016EEF831Q38237132-6BEC9050-D899-48A8-A35D-FF51C722EC75Q38289932-7D6323E6-68C7-457B-8400-CC0F4F727FF9Q38353973-A9F62293-42CE-4206-846A-A6E9FC40B3F4Q38541697-D7451631-7574-48BA-821D-F60DD1B4508DQ39221358-2863160D-3A22-43AB-84F6-D0C487F296F1Q40598448-E7C72D9C-86CD-4CD0-B5A7-A54500A9FA53Q43141010-53A9AD90-CA16-49DA-A7A8-F28690ABAF4FQ47222077-E7588DBF-5504-43D3-9F99-BE66C5E15187Q47786647-558FF28C-734B-458D-B88E-93ACFBC02311Q47799774-0BB093C0-66F2-41F9-8D4A-BEB1DF825B7BQ47861451-8D793225-2BD9-460A-9F24-CD14B5981611Q49480321-1D40E739-7BAD-459C-BA70-DAC301CE8D8BQ50893422-AD918FA4-EF76-46CF-9E23-5CD25B6E6A82Q52718548-029884F8-439A-4EAB-A79A-AE96A4537C9FQ55446160-AAF215D6-DB88-498B-B2EA-CFC9F9040E4C
P2860
2'-OMe-phosphorodithioate-modified siRNAs show increased loading into the RISC complex and enhanced anti-tumour activity.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
2'-OMe-phosphorodithioate-modi ...... enhanced anti-tumour activity.
@ast
2'-OMe-phosphorodithioate-modi ...... enhanced anti-tumour activity.
@en
type
label
2'-OMe-phosphorodithioate-modi ...... enhanced anti-tumour activity.
@ast
2'-OMe-phosphorodithioate-modi ...... enhanced anti-tumour activity.
@en
prefLabel
2'-OMe-phosphorodithioate-modi ...... enhanced anti-tumour activity.
@ast
2'-OMe-phosphorodithioate-modi ...... enhanced anti-tumour activity.
@en
P2093
P2860
P50
P356
P1476
2'-OMe-phosphorodithioate-modi ...... enhanced anti-tumour activity.
@en
P2093
Anil K Sood
Barbara Nawrot
Carlos Martinez
Chad V Pecot
Chandra Kovvali
Gabriel Lopez-Berestein
Heather J Dalton
Hee-Dong Han
Ji Hoon Kim
P2860
P2888
P356
10.1038/NCOMMS4459
P407
P50
P577
2014-03-12T00:00:00Z
P5875
P6179
1012360864